ClinicalTrials.gg
Enrolling by invitationNCT07893184PREPA-STERUpdated Oct 23, 2026

Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via Sternotomy

An interventional study of Physical Prehabilitation Intervention in Prehabilitation, Cardiac Surgery and Risk Assesment, sponsored by Maastricht University Medical Center. Enrolling by invitation at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Other

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Rationale Cardiac surgery via median sternotomy carries an elevated risk of postoperative complications and delayed functional recovery. Preoperative physical therapy aims to reduce the incidence and severity of postoperative adverse outcomes and to accelerate functional recovery. However, current evidence on prehabilitation is inconsistent due to methodological heterogeneity. This study addresses the limitations of previous studies in four ways. First, a validated preoperative prediction model is used to select patients at high risk of in-hospital postoperative complications and delayed functional recovery. Second, a Cardiopulmonary Exercise Test (CPET) is performed at baseline to guide safe and effective intensity prescription. Third, as different patient populations are expected to benefit from different training programs, the prehabilitation program is tailored to the surgical indication: patients undergoing coronary artery bypass grafting (CABG) receive high-intensity interval training (HIIT), and patients undergoing aortic valve replacement (AVR) receive moderate continuous training. Fourth, physical activity and self-management are promoted by using a wearable physical activity monitor and Shared Decision-Making (SDM) to stimulate and track daily physical activity.

Primary Objective To investigate the feasibility of a personalized, procedure-specific prehabilitation program (four to six weeks) for high-risk patients scheduled for elective cardiac surgery via sternotomy, with respect to recruitment, adherence, drop-out, safety, and acceptance. The program consists of two physiotherapist-supervised group training sessions per week, promotion of physical activity, and unsupervised home-based exercise.

Secondary Objective To provide a preliminary evaluation of participant responses to the intervention, focusing on changes in cardiorespiratory fitness (WRpeak), peripheral muscle strength (1RM), inspiratory muscle strength (MIP), physical activity (time spent active per day), and health-related quality of life (SF-36).

Study design A prospective, single-center, longitudinal, mixed-methods pilot study conducted at Maastricht University Medical Center (MUMC+).

Study population High-risk patients (n=24), defined by EuroSCORE II, who are scheduled for elective cardiac surgery via sternotomy (CABG or AVR).

Main study parameters/endpoints The primary endpoint is the feasibility of the prehabilitation intervention with respect to recruitment, adherence, drop-out, safety, and acceptance.

Burden Participation involves a structured time commitment with clinic and home components. Total supervised clinic time is estimated at 11-15 hours, covering two baseline assessments, 8-12 training sessions, and the final evaluation and interview. Total time at home is estimated at 16.5-19 hours, covering daily diary completion and unsupervised home exercises. These ranges depend on the patient's time to surgery.

Risks and mitigation The risk of acute cardiac events during exercise is elevated in this high-risk population. This risk is mitigated by strict adherence to NVVC/MUMC+ absolute stop criteria, continuous medical supervision during all testing and training sessions, and individualized intensity prescription based on CPET. The risk is considered acceptable in relation to the scientific value of studying this specific high-risk cohort, which makes the study group-related.

Benefit and group relatedness Direct clinical benefit cannot be guaranteed, as this is a feasibility study. However, patients receive an intensive, personalized prehabilitation program that is designed to reduce the incidence and severity of postoperative adverse outcomes.

Read the detailed description

Cardiac surgery performed via median sternotomy is associated with a substantial risk of postoperative complications and delayed functional recovery. Preoperative physical therapy has been proposed as a strategy to optimize patients' physiological reserve before surgery and to improve postoperative outcomes. Although interest in prehabilitation for patients awaiting cardiac surgery has grown over the past decade, current evidence remains inconclusive due to several methodological limitations in the literature.

Addressing Methodological Gaps

The proposed study addresses four critical limitations of previous research:

  1. Lack of objective risk stratification

    Most studies investigating prehabilitation have enrolled patients awaiting cardiac surgery without accounting for individual surgical risk, preoperative physical fitness, or frailty. These factors are known to independently predict adverse postoperative outcomes. Few studies to date have attempted to target "high-risk" patients, and those that did relied on general selection criteria (e.g., age >65 years, sedentary behavior, or clinical frailty). Crucially, none have used a validated prediction model to objectively identify the patients most likely to benefit. The most recently published randomized controlled trial, by López-Hernández et al., recommended that future research focus on improving risk stratification and identifying subgroups most likely to benefit.

    The investigators hypothesize that preoperative screening is needed to identify patients truly in need of prehabilitation, so that the intervention can be targeted to those most likely to gain clinical benefit. This pilot study directly addresses this primary gap.

    To address this limitation, the investigators recently developed and internally validated prediction models that classify patients as high- or low-risk for postoperative in-hospital complications and delayed recovery of physical functioning. The classification consists of a two-stage screening process. Patients with an elevated surgical risk (measured by the EuroSCORE II) undergo further screening with a multivariable prediction model. This model integrates surgical risk (EuroSCORE II), cardiorespiratory fitness (FITmáx), and frailty (Edmonton Frail Scale, EFS). The investigators hypothesize that prehabilitation is particularly beneficial for patients classified as high-risk by this model, ensuring that specialized care is delivered to those most in need.

  2. Suboptimal cardiorespiratory fitness assessment

    The majority of previous studies performed suboptimal baseline testing of cardiorespiratory fitness, resulting in insufficient exercise intensity during the prehabilitation period. Most trials prescribed training intensities based on submaximal tests such as the six-minute walk test (6MWT) or formula-based heart rate estimates. Both lack the precision to accurately quantify cardiorespiratory fitness and to guide an appropriate exercise prescription. Consequently, it remains unknown whether these patients received an adequate training stimulus.

    Only two studies have used Cardiopulmonary Exercise Testing (CPET), the gold standard for quantifying cardiorespiratory fitness and guiding individualized training intensity. Steinmetz et al. administered CPET-guided endurance training (2 × 10 minutes per session), whereas López-Hernández et al. applied a CPET-guided interval training protocol consisting of 2-minute high-intensity and 3-minute low-intensity intervals. Although both studies reported improvements in 6MWT distance, only the latter showed significant gains in maximal oxygen uptake (VO2max), suggesting that training modality and intensity are critical determinants of the physiological response. To address this second limitation, the study therefore includes a baseline CPET with two explicit goals: first, to ensure that the chosen training intensities provide an adequate training stimulus, and second, to ensure that these intensities are safe.

  3. Patient heterogeneity and uniform protocols

    Patients undergoing cardiac surgery form a heterogeneous population, differing substantially in underlying cardiac disease and planned surgical procedure. Previous prehabilitation studies have largely used a single, uniform preoperative training protocol, irrespective of the underlying disease or anticipated surgery.

    The investigators hypothesize, however, that the training program must be adapted to the underlying cardiac disease. Patients undergoing Coronary Artery Bypass Grafting (CABG) and Aortic Valve Replacement (AVR), for instance, differ significantly in cardiovascular pathophysiology and hemodynamic responses to exercise. Patients awaiting CABG typically present with coronary artery disease and may tolerate high-intensity interval training (HIIT), whereas patients awaiting AVR often exhibit fixed cardiac output and are potentially at higher risk during peak exertion. Procedure-specific training protocols and stratified analyses are therefore warranted.

    To address this third limitation, and given that HIIT produces greater improvements in cardiorespiratory fitness than moderate-intensity continuous training (MICT), the study proposes CPET-guided, procedure-specific training: HIIT for CABG patients and MICT for AVR patients.

  4. Inadequate monitoring of daily physical activity

A poor preoperative physical activity level is another known risk factor for adverse postoperative outcomes after cardiac surgery. Many previous prehabilitation trials either did not systematically monitor and stimulate daily physical activity (PA) or relied on subjective self-report questionnaires with limited reliability. This methodological gap resulted in inadequate promotion and objective monitoring of PA in daily life outside of supervised sessions.

To address this fourth limitation, and to enhance self-management and adherence, the program integrates validated, objective PA monitoring using a wearable physical activity monitor (accelerometer). To promote sustained PA behavior, objective feedback is coupled with individualized goal setting guided by Shared Decision-Making (SDM) between patient and physiotherapist. This strategy ensures that feedback is precise and patient-aligned, which is crucial for sustained behavioral change.

Novel elements

To address these gaps, the proposed study introduces four novel elements:

  1. Delivering physical prehabilitation to patients classified as high-risk for postoperative complications and delayed recovery of physical functioning.
  2. Prescribing individualized training intensities based on CPET.
  3. Targeting two homogeneous patient populations, each receiving a procedure-specific training program.
  4. Incorporating objective physical activity monitoring and Shared Decision-Making to promote self-management and improve physical activity behavior.
02

Conditions studied

  • Prehabilitation
  • Cardiac Surgery
  • Risk Assesment
  • Aortic Valve
  • Coronary Artery Bypass Graft
  • Training

Keywords

  • Prehabilitation
  • Perioperative care
  • Cardiac surgery
  • CABG
  • AVR
  • Training intervention
  • Promotion of physical activity
  • Interval training
  • CPET
  • Preoperative exercise
  • preoperative training
03

In context

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 852 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: ≥18 years.
  • Surgical procedure: Scheduled to undergo elective CABG or AVR via median sternotomy;

    • Allowed concomitant procedures: Isolated procedures or in combination with concomitant procedures (i.e., MAZE, Pulmonary Vein Isolation (PVI), clip Left Arterial Appendage (LAA)).
  • High risk classification: Classified as High-Risk for postoperative complications or delayed functional recovery, identified via a two-stage screening process:

    • Elevated Surgical Risk (Stage 1): Defined by a EuroSCORE II ≥1.33.
    • Multivariable Confirmation (Stage 2): Further screening using the prediction model that integrates EuroSCORE II, cardiorespiratory fitness (FITmáx), frailty (EFS), and BMI.
  • Waiting time: Expected waiting time > 4 weeks before surgery
  • Communication: Able to understand and communicate in Dutch.

Exclusion criteria

Exclusion Criteria:

  • Procedure-related: Scheduled for combined CABG and AVR, or combined with MVP and/or TVP, or combined with aortic aneurysm repair
  • Medical conditions, as described in the electronic medical record (EMR):

    • Patients with a known Ascending Aorta Diameter (AAD) >45mm or any patient with an AAD > 40mm if they have an associated high-risk condition, including a known genetic connective tissue disorder or a history of aortic dissection.
    • Recent acute coronary syndrome (\< 3 weeks)
    • Recent inflammatory myo-pericardial syndrome (\< 1 month after remission) as recommended in the ESC Guidelines for the management of myo- and peri-carditis
    • Conduction disturbances and/or arrhythmias with pacemaker (PM) or Implant-able Cardioverter Defibrillator (ICD) indication without a device implanted yet.
    • Decompensated heart failure or cardiomyopathy contraindicating exercise.
    • Atrial fibrillation or other tachyarrhythmias with resting heart rate >120 bpm.
  • Exercise and functional limitations, as described in the EMR:

    • Left main coronary artery stenosis >80%
    • History of frequent exercise-induced syncope's in Aortic valve Stenosis (AoS) and Aortic valve Insufficiency (AoI) patients
    • Physical impairments that makes it impossible to complete the assessments and the prehabilitation program, as determined by an experienced physiother-apist.
    • Cognitive impairment (e.g. dementia) that would impede understanding of study procedures, informed consent, or study questionnaires described by the medical specialist in the EMR.
    • Incapacitated subjects as reported by the attending medical specialist in the medical record. (When any doubt arises, the patient will not be considered eligible).
  • Exercise safety issues during the CPET at baseline measurement

    • Serious-exercise induced ischemia
    • Serious exercise-induced (supra-)ventricular arrhythmias
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    High risk patients awaiting Coronary Artery Bypass Grafting or Aortic Valve Replacement

    Elective patients awaiting cardiac surgery via sternotomy (CABG or AVR) and are considerd through a two stage screening proces as high risk for in-hospital complications or delayed recovery of physical functioning. two-stage screening process: * Elevated Surgical Risk (Stage 1): Defined by a EuroSCORE II ≥1.33. * Multivariable Confirmation (Stage 2): Further screening using the prediction model that integrates EuroSCORE II, cardiorespiratory fitness (FITmáx), frailty (EFS), and BMI.

    Behavioral: Physical Prehabilitation Intervention

Interventions

  • BehavioralPhysical Prehabilitation Intervention

    All study participants will undergo elective CABG or AVR within approximately five weeks or more following baseline assessment. The preoperative physical inter-vention will span a minimum of four to a maximum of six weeks (which means that they minimally participated in 8 to maximal 12 supervised training sessions) and consists of: • Two physiotherapist-supervised group training sessions per week consisting of: 1.Cardiorespiratory Fitness Training (based on CPET): CABG follow interval training; AVR follow continue training; 2.Peripheral Muscle Strength Training; 3.Inspiratory Muscle Strength Training (on indication); • Promotion of physical activity using wearable physical activity monitoring and goal-setting tailored to the individual's capacity and preferences.• Unsupervised home-based exercise (e.g., walking or cycling, strength exercises) tailored to the individual's capacity and preferences.

    Also known as: Preoperative physical exercise, Prehabilitation

06

What researchers measure

Primary outcomes

  1. Recruitment - Recruitment rate

    Number of included patients within the study period (n,%)

    Time frame: Week 0

  2. Recruitment (Ineligibility rate due to CPET safety criteria

    Number of patients withdrawn due to safety criteria (n,%)

    Time frame: Week 0

  3. Adherence - Attendance rate for physiotherapist-supervised groups sessions

    Number of attended sessions / total number of planned sessions (n,%)

    Time frame: Week 0-4~6

  4. Adherence rate - Exercise Relative Dose Intensity ExRDI cardiorespiratory training (%)

    ExRDI cardiorespiratory training = completed exercise dose intensity / prescribed exercise dose intensity. Interval training (CABG) • Completed = Σ (completed work-interval duration \[min\] × completed work rate \[WR\]). • Prescribed = Σ (prescribed work-interval duration \[min\] × prescribed work rate \[WR\]). Continuous training (AVR) • Completed = total completed duration \[min\] × completed work rate \[WR\]. • Prescribed = total prescribed duration \[min\] × prescribed work rate \[WR\]. ExRDI cardiorespiratory training is calculated for each participant individually, cumulative for all training sessions; and cumulative for all participants.

    Time frame: Week 0-4~6

  5. Adherence rate - EXRDI peripheral strength training (%)

    ExRDI peripheral strength training = completed exercise dose intensity / prescribed exercise dose intensity. * Completed = completed weight \[kg\] × sets \[N\] × repetitions \[N\] per exercise. * Prescribed = prescribed weight \[kg\] × sets \[N\] × repetitions \[N\] per exercise. ExRDI peripheral strength training is calculated per participant per training session for each exercise and for all four exercises cumulative. And cumulative for all training sessions; and cumulative for all participants.

    Time frame: Week 0-4~6

  6. Adherence rate - ErXDI inspiratory strength training (%)

    ExRDI inspiratory strength training = completed exercise dose intensity / prescribed exercise dose intensity. * Completed volume = completed resistance × sets \[N\] × repetitions \[N\]. * Prescribed volume = prescribed resistance × sets \[N\] × repetitions \[N\]. ExRDI inspiratory strength training will be calculated once weekly for each participant during the supervised training session. The weekly value will be accumulated across all supervised sessions and aggregated across participants. For unsupervised inspiratory strength training, diary entries will be reviewed with the participant during the weekly supervised session. Patients will record the number of sets and repetitions performed each day, from which the completed exercise dose intensity will be derived. Prescribed volumes will be based on the individual's target resistance, sets, and repetitions for that week. Supervised and unsupervised ExRDI values will be calculated and analyzed separately.

    Time frame: Week 0-4~6

  7. Adherence - ExRDI Physical activity and unsupervised home-based exercises (%)

    ExRDI physical activity and unsupervised home-based exerises = completed physical activity volume / prescribed physical activity volume. * Completed volume = PAM measured activity (min/day) * Prescribed volume = goal activity (min/day) ExRDI physical activity and unsupervised home-based exercises is calculated and evaluated per participant in the week during supervised training session. And cumulative for all weeks; and cumulative for all participants.

    Time frame: Week 0-4~6

  8. Reasons for not having executed a training session as intended

    Reasons for not having executed a training session as intended (e.g., low saturation, high blood pressure, the intended training intensity could not be sustained, tiredness, etc.)

    Time frame: Week 0-4~6

  9. Reasons for not having executed a training session as intended stratified by trainings type

    Reasons for not having executed a training session as intended (e.g., low saturation, high blood pressure, the intended training intensity could not be sustained, tiredness, etc.)

    Time frame: Week 0-4~6

  10. Drop-out rate (%)

    Number of participants who dropped out divided by the total number of participants

    Time frame: Week 0-4~6

  11. Reasons for drop-out

    Reasons for drop-out

    Time frame: Week 0-4~6

  12. Acceptance - Experiences with the physical prehabilitation intervention

    Patient-reported experiences with the prehabilitation program (semi-structured interviews).

    Time frame: Evaluation (after the whole training intervention).

  13. Acceptance - Suitability of the physical prehabilitation intervention and study procedures

    Patient-perceived suitability of the intervention and study procedures (semi-structured interviews).

    Time frame: Evaluation (after the whole training intervention).

  14. Acceptance - Barriers and enablers regarding participation in the study

    Patient-perceived barriers and facilitators to participation (semi-structured interviews).

    Time frame: Evaluation (after the whole training intervention).

Secondary outcomes

  1. Safety - Serious adverse events

    A serious adverse event (n, %) is any untoward medical occurrence or effect that * results in death; * is life threatening (at the time of the event); * requires hospitalization or prolongation of existing inpatients' hospitalization; * results in persistent or significant disability or incapacity; * is a congenital anomaly or birth defect; or * any other important medical event that did not result in any of the outcomes listed above due to medical or surgical intervention but could have been based upon appropriate judgement by the investigator. An elective hospital admission will not be considered as a serious adverse event. In addition, within the context of this study, events such as (near-)collapse, chest pain, palpitations, or the use of emergency medication will be classified as SAEs if they meet the criteria outlined above (e.g., leading to EHH evaluation, hospitalization, or acute medical intervention).

    Time frame: From baseline to three month after surgery

  2. Safety - Study related adverse events

    The following events are considered potentially study-related adverse events (n,%) when occurring during or in temporal relation to the intervention: * early termination of the training, because of the occurrence of one of the subjective or objective termination criteria (as described in section 5.1) * (near-)collapse * severe muscle pain lasting \>2 days * dizziness * severe nausea * palpitations or chest pain during exertion * administration of pre-defined medication as needed (pro re nata, PRN) (e.g., Nitroglycerin) for acute symptoms arising during or immediately following the intervention. Temporal classification rule: * Events occurring during or within 1 hour after a training session are considered directly intervention-related unless proven otherwise. * Events occurring more than 1 hour after the intervention are assessed on a case-by-case basis by the responsible physician, taking into account clinical context, temporal relationship, and alternative explanations.

    Time frame: From baseline to three month after surgery

  3. Preliminary evaluation of changes in cardiorespiratory fitness

    * WRpeak (W/kg) as determined by the Steep Ramp Test (SRT) * Estimated VO2max (ml/kg/min) determined by FitMáx.

    Time frame: Baseline (Week 0) and evaluation (after the whole training intervention).

  4. Preliminary evaluation of changes in peripheral muscle strength

    -8-10-repetition maximum (8-10-RM, kg) determined indirectly via validated submaximal RM tests on leg press, chest press, leg extension, and vertical traction equipment.

    Time frame: Baseline (Week 0) and evaluation (after the whole training intervention).

  5. Preliminary evaluation of changes in inspiratory muscle strength

    -Maximum Inspiratory Pressure (MIP) (cmH2O)

    Time frame: Baseline (Week 0) and evaluation (after the whole training intervention).

  6. Physical activity behaviour and home based exercise program

    Physical activity is measured objectively using the ankle-worn PAM AM500 3-axis accel-erometer (min/day)

    Time frame: Continuously during intervention.

  7. Postoperative in-hospital complications

    Data extraction of usual care data for Nederlandse Hart Regristratie (NHR). (n,%)

    Time frame: After hospitalization/ discharge

  8. Postoperative recovery of functioning

    Data extraction of usual care data modified Iowa Level of Assistance Scale (mILAS) daily assessments by a physiotherapist (days til independence)

    Time frame: After hospitalization/ discharge

07

Study locations

1 site
  • Maastricht University Medical Center
    Maastricht, Limburg 6229HX, Netherlands
08

References and documents

Publications

  • Marmelo F, Rocha V, Moreira-Goncalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018 Mar;25(4):404-417. doi: 10.1177/2047487317752373. Epub 2018 Jan 17. PubMed 29338307 ↗
  • Steinmetz C, Bjarnason-Wehrens B, Walther T, Schaffland TF, Walther C. Efficacy of Prehabilitation Before Cardiac Surgery: A Systematic Review and Meta-analysis. Am J Phys Med Rehabil. 2023 Apr 1;102(4):323-330. doi: 10.1097/PHM.0000000000002097. Epub 2022 Sep 23. PubMed 36149383 ↗
  • Lopez-Hernandez A, Gimeno-Santos E, Navarro-Ripoll R, Arguis MJ, Lopez-Baamonde M, Sanz-de la Garza M, Sandoval E, Castella M, Martinez-Palli G. Multimodal prehabilitation as a strategy to reduce postoperative complications in cardiac surgery: A randomised controlled trial. Eur J Anaesthesiol. 2025 Nov 1;42(11):987-996. doi: 10.1097/EJA.0000000000002236. Epub 2025 Jul 16. PubMed 40673713 ↗
  • van der Hoofd Z, van Dijk-Huisman HC, Bongers BC, Scheenstra B, Maessen J, Lenssen AF. Preoperative Physical Fitness and Short-Term Postoperative Outcomes in Patients Undergoing Elective Cardiac Surgery: A Retrospective Cohort Study. Semin Cardiothorac Vasc Anesth. 2026 Sep;30(3):160-171. doi: 10.1177/10892532261427827. Epub 2026 Feb 21. PubMed 41721796 ↗
  • van der Hoofd, Z., et al., Predicting In-Hospital Complications and Delayed Recovery in Patients undergoing Cardiac Surgery via Sternotomy: Development and Internal Validation of Multivariable Predictions Models Submitted, 2025.
  • Steinmetz C, Bjarnason-Wehrens B, Baumgarten H, Walther T, Mengden T, Walther C. Prehabilitation in patients awaiting elective coronary artery bypass graft surgery - effects on functional capacity and quality of life: a randomized controlled trial. Clin Rehabil. 2020 Oct;34(10):1256-1267. doi: 10.1177/0269215520933950. Epub 2020 Jun 16. PubMed 32546065 ↗

Individual participant data

Plan to share: Undecided — Individual Participant Data (IPD) will be shared upon reasonable request. Requests will be reviewed individually.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Jun 2027, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 31, 2025
First posted
Oct 23, 2026
StartActual
Sep 17, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Aug 30, 2027
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07893184
Responsible party
Sponsor
First posted
Oct 23, 2026
Start date
Sep 17, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion